What does DR. VAN DROOGENBROECK, Algemene Geneeskunde” do?

DR. VAN DROOGENBROECK, Algemene Geneeskunde” is a general practice in Aalst. Private Limited, started on 24 May 2018, 2 establishments.

What is the address of DR. VAN DROOGENBROECK, Algemene Geneeskunde”?

The registered office of DR. VAN DROOGENBROECK, Algemene Geneeskunde” is located at Désiré De Wolfstraat 11, 9300 Aalst.

Is DR. VAN DROOGENBROECK, Algemene Geneeskunde” still active?

Yes. According to the CBE (30 September 2026) DR. VAN DROOGENBROECK, Algemene Geneeskunde” is active, legal situation “Normale toestand”, started on 24 May 2018.

Is DR. VAN DROOGENBROECK, Algemene Geneeskunde” registered on Peppol?

Yes, DR. VAN DROOGENBROECK, Algemene Geneeskunde” is registered on the Peppol network with ID 0208:0696765252.

What is the enterprise number of DR. VAN DROOGENBROECK, Algemene Geneeskunde”?

The enterprise number of DR. VAN DROOGENBROECK, Algemene Geneeskunde” is BE0696765252.

When was DR. VAN DROOGENBROECK, Algemene Geneeskunde” founded?

DR. VAN DROOGENBROECK, Algemene Geneeskunde” was founded on 24 May 2018.

Who are the directors of DR. VAN DROOGENBROECK, Algemene Geneeskunde”?

According to the 2025 annual accounts, the directors of DR. VAN DROOGENBROECK, Algemene Geneeskunde” are: Hannelore Van Droogenbroeck.

Is DR. VAN DROOGENBROECK, Algemene Geneeskunde” a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 May 2018; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did DR. VAN DROOGENBROECK, Algemene Geneeskunde” make in 2025?

DR. VAN DROOGENBROECK, Algemene Geneeskunde” posted a profit after taxes of € 69,449 in financial year 2025.

What is the revenue of DR. VAN DROOGENBROECK, Algemene Geneeskunde”?

As a small company, DR. VAN DROOGENBROECK, Algemene Geneeskunde” is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 98,709.

DR. VAN DROOGENBROECK, Algemene Geneeskunde” (Private Limited)

Dossier DR. VAN DROOGENBROECK, Algemene Geneeskunde”, printed on 30 September 2026 from databakkes.be/en/0696765252/dr-van-droogenbroeck-algemene-geneeskunde. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. VAN DROOGENBROECK, Algemene Geneeskunde” from Aalst, company number BE0696765252, closed financial year 2025 with a result of € 69,449 after tax. For that financial year DR. VAN DROOGENBROECK, Algemene Geneeskunde” recorded a gross margin of € 98,709 and equity of € 21,262. Compared with financial year 2024, the result moved from € 73,999 to € 69,449. The company is profitable. The buffer shrank hard: equity is 63 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 28, 2026.

What it is worth Shrank hard

€ 21,262

▼ 63% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 69,449

▼ 6% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 72,506

▼ 28% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 105,449 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt ≈ 8 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 85,337

▼ 10% vs 2024

€ 10,030 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 1,122

▼ 58% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 2,490

▲ € 1,882 vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 75,263 Gross margin 2022: € 75,263 First fiscal year in the series	€ 92,623 Gross margin 2023: € 92,623 ▲ 23% vs 2022 (€ 75,263) Favourable step	€ 105,286 Gross margin 2024: € 105,286 ▲ 14% vs 2023 (€ 92,623) Favourable step	€ 98,709 Gross margin 2025: € 98,709 ▼ 6% vs 2024 (€ 105,286) Unfavourable step	▼ 6%
Profit after taxes	€ 44,928 Profit after taxes 2022: € 44,928 First fiscal year in the series	€ 58,631 Profit after taxes 2023: € 58,631 ▲ 30% vs 2022 (€ 44,928) Favourable step	€ 73,999 Profit after taxes 2024: € 73,999 ▲ 26% vs 2023 (€ 58,631) Favourable step	€ 69,449 Profit after taxes 2025: € 69,449 ▼ 6% vs 2024 (€ 73,999) Unfavourable step	▼ 6%
Equity	€ 57,262 Equity 2022: € 57,262 First fiscal year in the series	€ 57,262 Equity 2023: € 57,262 Unchanged (€ 57,262) Unchanged	€ 57,262 Equity 2024: € 57,262 Unchanged (€ 57,262) Unchanged	€ 21,262 Equity 2025: € 21,262 ▼ 63% vs 2024 (€ 57,262) Unfavourable step	▼ 63%
Total debts	€ 184,643 Total debts 2022: € 184,643 First fiscal year in the series	€ 178,763 Total debts 2023: € 178,763 ▼ 3% vs 2022 (€ 184,643) Favourable step	€ 177,850 Total debts 2024: € 177,850 ▼ 1% vs 2023 (€ 178,763) Favourable step	€ 177,740 Total debts 2025: € 177,740 Unchanged (€ 177,850) Favourable step
Cash	€ 92,801 Cash 2022: € 92,801 First fiscal year in the series	€ 99,152 Cash 2023: € 99,152 ▲ 7% vs 2022 (€ 92,801) Favourable step	€ 100,099 Cash 2024: € 100,099 ▲ 1% vs 2023 (€ 99,152) Favourable step	€ 72,506 Cash 2025: € 72,506 ▼ 28% vs 2024 (€ 100,099) Unfavourable step	▼ 28%
Land & buildings	€ 138,605 Land & buildings 2022: € 138,605 First fiscal year in the series	€ 130,414 Land & buildings 2023: € 130,414 ▼ 6% vs 2022 (€ 138,605) Unchanged	€ 125,689 Land & buildings 2024: € 125,689 ▼ 4% vs 2023 (€ 130,414) Unchanged	€ 117,149 Land & buildings 2025: € 117,149 ▼ 7% vs 2024 (€ 125,689) Unchanged	▼ 7%
Retained profit	€ 38,662 Retained profit 2022: € 38,662 First fiscal year in the series	€ 38,662 Retained profit 2023: € 38,662 Unchanged (€ 38,662) Unchanged	€ 38,662 Retained profit 2024: € 38,662 Unchanged (€ 38,662) Unchanged	€ 2,662 Retained profit 2025: € 2,662 ▼ 93% vs 2024 (€ 38,662) Unfavourable step	▼ 93%
Dividend	€ 44,928 Dividend 2022: € 44,928 First fiscal year in the series	€ 58,631 Dividend 2023: € 58,631 ▲ 30% vs 2022 (€ 44,928) Unchanged	€ 73,999 Dividend 2024: € 73,999 ▲ 26% vs 2023 (€ 58,631) Unchanged	€ 105,449 Dividend 2025: € 105,449 ▲ 43% vs 2024 (€ 73,999) Unchanged	▲ 43%
Bank debt	€ 124,702 Bank debt 2022: € 124,702 First fiscal year in the series	€ 108,899 Bank debt 2023: € 108,899 ▼ 13% vs 2022 (€ 124,702) Favourable step	€ 95,216 Bank debt 2024: € 95,216 ▼ 13% vs 2023 (€ 108,899) Favourable step	€ 85,337 Bank debt 2025: € 85,337 ▼ 10% vs 2024 (€ 95,216) Favourable step	▼ 10%
Balance sheet total	€ 241,905 Balance sheet total 2022: € 241,905 First fiscal year in the series	€ 236,025 Balance sheet total 2023: € 236,025 ▼ 2% vs 2022 (€ 241,905) Unchanged	€ 235,112 Balance sheet total 2024: € 235,112 Unchanged (€ 236,025) Unchanged	€ 199,003 Balance sheet total 2025: € 199,003 ▼ 15% vs 2024 (€ 235,112) Unchanged	▼ 15%

Key figures of DR. VAN DROOGENBROECK, Algemene Geneeskunde”, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. VAN DROOGENBROECK, Algemene Geneeskunde”?

What happened at DR. VAN DROOGENBROECK, Algemene Geneeskunde” in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 28, 2026 New annual accounts for financial year 2025: profit of € 69,449 (▼ 6% vs 2024). Source: NBB ↗
Nov 1, 2019 New establishment in Aalst. KBO
May 24, 2018 New establishment in Denderleeuw. KBO
2018 Hannelore Van Droogenbroeck became a director. NBB
May 24, 2018 Start of the company according to the CBE. KBO

In short

From € 44,928 profit in 2022 to € 69,449 profit in 2025.

Paid € 66,367 in corporate taxes since 2022.

Best year ever: 2024, with € 73,999 profit.

Paid out € 283,007 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. VAN DROOGENBROECK, Algemene Geneeskunde”? We notify you, reason included.

Follow DR. VAN DROOGENBROECK, Algemene Geneeskunde”

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Hannelore Van Droogenbroeck

DR. VAN DROOGENBROECK, Algemene Geneeskunde”

Behind DR. VAN DROOGENBROECK, Algemene Geneeskunde” is Hannelore Van Droogenbroeck.

See the full network in the app

Directors

According to the 2025 annual accounts

Hannelore Van Droogenbroeck

Director

since 2018

Establishments

Establishment units

Physical locations of this company

Registered office

Désiré De Wolfstraat 11

9300 Aalst

2.296.139.854

Regentiestraat 12

9473 Denderleeuw

Active since 24 May 2018

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0696.765.252
VAT number: BE 0696.765.252
Registered office: Désiré De Wolfstraat 11, 9300 Aalst
Names & denominations: DR. VAN DROOGENBROECK, Algemene Geneeskunde”
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 24 May 2018
Peppol: Active · Active since 23 Jun 2025
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗